The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...
The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...
Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...
UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...
Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...
Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...
The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...
Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...
Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...
Amazon Web Services (AWS) has committed $100 million in AI and cloud technology capacity to support the building of health ...
Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock Ventures (TRV), focused on using its AI platform to discover novel biologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results